Cerevance Media Center

Current News

April 19, 2022

Cerevance Announces Leadership Transition to Implement Next Phase of Growth in Advancing Novel Therapeutics for Brain Diseases

Cerevance today announced the appointment of Craig Thompson to chief executive officer. Mr. Thompson brings over 25 years of commercial and marketing leadership experience in the biotech and pharmaceutical industries to the company.

READ FULL

March 31, 2022

Cerevance Reports Positive Phase 2 Clinical Trial Results with CVN424, a Parkinson’s Disease Drug Working Through a New Mechanism

Cerevance today announced the completion of its Phase 2 clinical trial of CVN424, the company’s first-in-class, once-a-day, orally-delivered compound in development for the treatment of Parkinson’s disease.

READ FULL

January 25, 2022

Cerevance Doses First Subjects in Phase 1 Clinical Trial of CVN766

Cerevance Doses First Subjects in Phase 1 Clinical Trial of CVN766

READ FULL

September 8, 2021

Neuroscience Drug Development Veteran Mike Poole, M.D., FACP, to Join Cerevance Board of Directors

Cerevance today announced the appointment of Mike Poole, M.D., FACP, to Cerevance’s Board of Directors.

READ FULL

News Archive

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
No items found.

April 29, 2024

Cerevance to Participate at Wells Fargo Virtual Private Biotech Symposium

Date:
Monday, May 6, 2024
Time:
Per meeting scheduling
Location:
Virtual
Media:
Scheduled Meetings
Read full

April 29, 2024

Cerevance to Present at RBC Capital Markets 2024 Global Healthcare Conference

Date:
Wednesday, May 15, 2024
Time:
11:30 am ET
Location:
New York
Media:
Oral Presentation
Read full

April 17, 2024

Cerevance Presents at 35th Symposium on Medicinal Chemistry in Eastern England

Date:
Thursday, April 25, 2024
Time:
2:35pm BST
Location:
Hatfield, United Kingdom
Media:
Oral Presentation
Read full

Events Archive

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
No items found.

August 14, 2023

A Covalent Binding Mode of a Pyrazole-Based CD38 Inhibitor

Doyle, K., Roberts, M., Harvey, J, Hewer, R., Zebisch, M., Rangel, V., Gu, M., Wu, Y., Yang, L., Carlton, M., Dawson, L. & Bürli, R.

Viewview

October 15, 2018

Species and Cell-Type Properties of Classically Defined Human and Rodent Neurons and Glia

Xu, X., Stoyanova, E.I., Lemiesz, A.E., Xing, J., Mash, D.C., Heintz, N.

Viewview